Date: 2012-03-05
Type of information: Establishment of a new subsidiary in the EU
Company: AB Science (France)
Investors:
Amount: €10 million
Funding type:
Planned used:
Others: AB Science has issued a bond loan agreement, convertible or repayable in ordinary shares, for the nominal amount of 10,000,500 euros in a private arrangement. The bonds bear 1.25% interest to be paid annually. They also bear 4.75% accrued interest to be paid only in case of repayment of the loan in cash. The bonds are convertible into shares at any time at the initiative of the bondholder at the price of 15,00 euros per share. The bonds may be repaid by anticipation in cash at the option of AB Science under certain conditions. They will be repayable in full on the seventh anniversary of the issue date at their nominal value.
Therapeutic area: Cancer - Oncology - Autoimmune diseases - Neurodegenerative diseases
